Serum YKL-40 as a potential biomarker of inflammation in psoriasis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2017.1330529
Abstract: Abstract Objective: YKL-40 is an inflammatory glycoprotein associated with atherosclerosis, cardiovascular disease, diabetes or metabolic syndrome which are common comorbidities in psoriasis. The aim of the study was to assess serum YKL-40 level in psoriasis… read more here.
Keywords: ykl potential; serum ykl; treatment; inflammation ... See more keywords